Purification of recombinant Vaccinia virus for oncolytic and immunotherapeutic applications using monolithic column technology
Vaccinia virus Lister strain, a large, structurally complex double stranded DNA pox virus, is being developed by a number of organisations around the world as an oncolytic and immunotherapeutic agent for the treatment of a broad range of cancers. Should these therapies prove to be efficacious in the...
Main Author: | |
---|---|
Published: |
University College London (University of London)
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.747038 |